Menin inhibitors have demonstrated profound preclinical activity in MLL1-rearranged and NPM1 mutated AML and in this context, ziftomenib is a novel compound currently assessed in a clinical phase I/II
This dataset contains data from two acute myeloid leukaemia (AML) specimens processed with the Illumina CytoSNP-12 SNP array platform. SNP array data showed evidence of chromothripsis in these two spe
To investigate the effects of circRNA in AML, we collected the PBMC of AML patients and healthy volunteers and performed high-throughput sequencing, the results showed that circRNA_01 was differential